Variant report

Variant	nsv963697
Chromosome Location	chr2:111436714-111437992
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:167)
CpG islands
(count:61)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:167 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:111436844-111437360	K562	blood:	n/a	n/a
2	BACH1	chr2:111436617-111437068	K562	blood:	n/a	n/a
3	BACH1	chr2:111436880-111437064	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr2:111435201-111436778	GM12878	blood:	n/a	n/a
5	BHLHE40	chr2:111435601-111437823	K562	blood:	n/a	n/a
6	CCNT2	chr2:111436711-111437205	K562	blood:	n/a	n/a
7	CEBPB	chr2:111436920-111437319	K562	blood:	n/a	n/a
8	CHD1	chr2:111434776-111436780	GM12878	blood:	n/a	chr2:111435475-111435485
9	CTCF	chr2:111436920-111437070	RPTEC	kidney:	n/a	n/a
10	CTCF	chr2:111436840-111437130	Caco-2	colon:	n/a	n/a
11	CTCF	chr2:111437040-111437190	HL-60	blood:	n/a	n/a
12	CTCF	chr2:111436980-111437130	HCM	heart:	n/a	n/a
13	CTCF	chr2:111436960-111437110	NB4	blood:	n/a	n/a
14	CTCF	chr2:111436960-111437110	HCPEpiC	choroid plexus:	n/a	n/a
15	CTCF	chr2:111437002-111437073	GM10266	blood:	n/a	n/a
16	CTCF	chr2:111436844-111437472	K562	blood:	n/a	n/a
17	CTCF	chr2:111436980-111437130	GM12873	blood:	n/a	n/a
18	CTCF	chr2:111436940-111437090	HUVEC	blood vessel:	n/a	n/a
19	CTCF	chr2:111436962-111437049	GM10248	blood:	n/a	n/a
20	CTCF	chr2:111437020-111437170	HVMF	connective:	n/a	n/a
21	CTCF	chr2:111436943-111437071	LNCaP	prostate:	n/a	n/a
22	CTCF	chr2:111436900-111437050	GM12864	blood:	n/a	n/a
23	CTCF	chr2:111436980-111437130	HEEpiC	esophagus:	n/a	n/a
24	CTCF	chr2:111436800-111436950	AG10803	skin:	n/a	n/a
25	CTCF	chr2:111436970-111437079	SK-N-SH_RA	brain:	n/a	n/a
26	CTCF	chr2:111436860-111437010	GM12866	blood:	n/a	n/a
27	CTCF	chr2:111436880-111437030	HMF	breast:	n/a	n/a
28	CTCF	chr2:111436940-111437090	BJ	skin:	n/a	n/a
29	CTCF	chr2:111436948-111437128	Spleen_OC	spleen:	n/a	n/a
30	CTCF	chr2:111436940-111437090	HRPEpiC	eye:	n/a	n/a
31	CTCF	chr2:111436920-111437070	NHDF-neo	bronchial:	n/a	n/a
32	CTCF	chr2:111436960-111437110	BJ	skin:	n/a	n/a
33	CTCF	chr2:111437000-111437150	GM12871	blood:	n/a	n/a
34	CTCF	chr2:111436900-111437050	A549	lung:	n/a	n/a
35	CTCF	chr2:111436864-111437172	GM12878	blood:	n/a	n/a
36	CTCF	chr2:111436940-111437090	GM12872	blood:	n/a	n/a
37	CTCF	chr2:111436940-111437090	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr2:111436940-111437090	AG10803	skin:	n/a	n/a
39	CTCF	chr2:111437000-111437150	GM12864	blood:	n/a	n/a
40	CTCF	chr2:111436840-111436990	RPTEC	kidney:	n/a	n/a
41	CTCF	chr2:111436939-111437118	GM12878	blood:	n/a	n/a
42	CTCF	chr2:111436960-111437110	AG09319	gingival:	n/a	n/a
43	CTCF	chr2:111436850-111437217	IMR90	lung:	n/a	n/a
44	CTCF	chr2:111436920-111437070	K562	blood:	n/a	n/a
45	CTCF	chr2:111436880-111437030	HEEpiC	esophagus:	n/a	n/a
46	CTCF	chr2:111436920-111437070	GM06990	blood:	n/a	n/a
47	CTCF	chr2:111436840-111436990	HRE	kidney:	n/a	n/a
48	CTCF	chr2:111436960-111437110	SK-N-SH_RA	brain:	n/a	n/a
49	CTCF	chr2:111437000-111437150	HPAF	blood vessel:	n/a	n/a
50	CTCF	chr2:111436971-111437071	GM13976	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:111437634-111437684	SK-N-SH	brain:	n/a
2	chr2:111437634-111437684	AG04449	skin:	fetal
3	chr2:111437634-111437684	NHBE	bronchial:	n/a
4	chr2:111437634-111437684	NT2-D1	testis:	n/a
5	chr2:111437634-111437684	NH-A	brain:	n/a
6	chr2:111437634-111437684	HNPCEpiC	eye:	n/a
7	chr2:111437634-111437684	HEK293	kidney:	embryo
8	chr2:111437634-111437684	T-47D	breast:	n/a
9	chr2:111437634-111437684	HL-60	blood:	n/a
10	chr2:111437634-111437684	Caco-2	colon:	n/a
11	chr2:111437634-111437684	PANC-1	pancreas:	n/a
12	chr2:111437634-111437684	SKMC	muscle:	n/a
13	chr2:111437634-111437684	ovcar-3	ovarian:	n/a
14	chr2:111437634-111437684	AG10803	skin:	n/a
15	chr2:111437634-111437684	HUVEC	blood vessel:	n/a
16	chr2:111437634-111437684	PFSK-1	brain:	n/a
17	chr2:111437634-111437684	SAEC	small airway:	n/a
18	chr2:111437634-111437684	AG09319	gingival:	n/a
19	chr2:111437634-111437684	SK-N-MC	brain:	n/a
20	chr2:111437634-111437684	HCT-116	colon:	n/a
21	chr2:111437634-111437684	AG09309	skin:	n/a
22	chr2:111437634-111437684	HCM	heart:	n/a
23	chr2:111437634-111437684	HEEpiC	esophagus:	n/a
24	chr2:111437634-111437684	BE2_C	brain:	n/a
25	chr2:111437634-111437684	HRPEpiC	eye:	n/a
26	chr2:111437634-111437684	RPTEC	kidney:	n/a
27	chr2:111437634-111437684	NB4	blood:	n/a
28	chr2:111437634-111437684	HMEC	breast:	n/a
29	chr2:111437634-111437684	GM12878	blood:	n/a
30	chr2:111437634-111437684	AoSMC	blood vessel:	n/a
31	chr2:111437634-111437684	ProgFib	skin:	n/a
32	chr2:111437634-111437684	HPAEpiC	pulmonary alveolar:	n/a
33	chr2:111437634-111437684	NHDF-neo	bronchial:	n/a
34	chr2:111437634-111437684	H1-hESC	embryonic stem cell:	embryo
35	chr2:111437634-111437684	HCPEpiC	choroid plexus:	n/a
36	chr2:111437634-111437684	BJ	skin:	n/a
37	chr2:111437634-111437684	U87	brain:	n/a
38	chr2:111437634-111437684	LNCaP	prostate:	n/a
39	chr2:111437634-111437684	GM12891	blood:	n/a
40	chr2:111437634-111437684	HIPEpiC	eye:	n/a
41	chr2:111437634-111437684	MCF-7	breast:	n/a
42	chr2:111437634-111437684	HRCEpiC	kidney:	n/a
43	chr2:111437634-111437684	IMR90	lung:	fetal
44	chr2:111437634-111437684	HepG2	liver:	n/a
45	chr2:111437634-111437684	SK-N-SH_RA	brain:	n/a
46	chr2:111437634-111437684	Hepatocyte	liver:	n/a
47	chr2:111437634-111437684	AG04450	lung:	fetal
48	chr2:111437634-111437684	HAEpiC	amniotic membrane:	n/a
49	chr2:111437634-111437684	PrEC	prostate:	n/a
50	chr2:111437634-111437684	GM12892	blood:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:111434111..111436826-chr2:111878321..111880919,2	K562	blood:
2	chr2:111409847..111412405-chr2:111435701..111437237,2	K562	blood:
3	chr2:111435750..111438683-chr2:111457735..111460578,3	K562	blood:
4	chr2:111435925..111437576-chr2:111510345..111513033,2	MCF-7	breast:

No data

Variant related genes	Relation type
BUB1	TF binding region
BUB1	CpG island
ENSG00000153094	chromatin interactions

Extended variants
information (count: 47 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:47 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369989747	chr2:111436748-111436749	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs565756895	chr2:111436756-111436757	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs111844173	chr2:111436773-111436774	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs377684250	chr2:111436775-111436776	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs544580836	chr2:111436777-111436778	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs533779284	chr2:111436788-111436789	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs554720865	chr2:111436809-111436810	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs141274209	chr2:111436812-111436813	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs536651387	chr2:111436820-111436821	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs536369971	chr2:111436828-111436829	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs577112032	chr2:111436854-111436855	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs529909480	chr2:111436856-111436857	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs182385286	chr2:111436865-111436866	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs552785374	chr2:111436882-111436883	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs572719580	chr2:111436979-111436980	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs541895940	chr2:111436981-111436982	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs561847843	chr2:111437028-111437029	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs72942137	chr2:111437038-111437039	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs184691266	chr2:111437053-111437054	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs564796049	chr2:111437094-111437095	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs533483572	chr2:111437211-111437212	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs200795615	chr2:111437216-111437217	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs534136781	chr2:111437230-111437231	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs547199573	chr2:111437254-111437255	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs202016977	chr2:111437317-111437318	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs150224494	chr2:111437381-111437382	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs536981414	chr2:111437526-111437527	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs548268077	chr2:111437532-111437533	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs560696295	chr2:111437552-111437553	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs13393728	chr2:111437560-111437561	Bivalent Enhancer Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs544752220	chr2:111437623-111437624	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs367901214	chr2:111437650-111437651	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs537047923	chr2:111437679-111437680	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs556712354	chr2:111437683-111437684	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs570711701	chr2:111437694-111437695	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs189097991	chr2:111437696-111437697	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs143064988	chr2:111437700-111437701	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs552873809	chr2:111437724-111437725	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs112469586	chr2:111437749-111437750	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs201952583	chr2:111437758-111437759	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs146255567	chr2:111437792-111437793	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs79858258	chr2:111437794-111437795	Bivalent Enhancer Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs73954654	chr2:111437828-111437829	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs374416331	chr2:111437838-111437839	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs555429882	chr2:111437915-111437916	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs575694429	chr2:111437934-111437935	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs13412431	chr2:111437965-111437966	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Ocular motor apraxia	21572526	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Idiopathic chronic pancreatitis	21549014	CNVD
Mental retardation	21549014	CNVD
Maculopathy	20981449	CNVD
Nephronophthisis	22470819	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Schizophrenia	23813976	CNVD
Developmental delay	21147756	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:217 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:111433800-111436800	Active TSS	ES-I3 Cell Line	embryonic stem cell
2	chr2:111434200-111436800	Active TSS	H1 Cell Line	embryonic stem cell
3	chr2:111434200-111436800	Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr2:111434200-111436800	Active TSS	NHDF-Ad	bronchial
5	chr2:111434200-111437200	Active TSS	K562	blood
6	chr2:111434200-111437200	Active TSS	NHLF	lung
7	chr2:111434600-111437000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr2:111434600-111437200	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
9	chr2:111434800-111436800	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
10	chr2:111435000-111436800	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
11	chr2:111435000-111436800	Active TSS	Brain Hippocampus Middle	brain
12	chr2:111435000-111436800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
13	chr2:111435000-111436800	Active TSS	Fetal Muscle Trunk	muscle
14	chr2:111435000-111436800	Active TSS	HSMMtube	muscle
15	chr2:111435200-111436800	Active TSS	Brain Angular Gyrus	brain
16	chr2:111435200-111436800	Active TSS	Colonic Mucosa	Colon
17	chr2:111435200-111436800	Active TSS	Pancreatic Islets	Pancreatic Islet
18	chr2:111435200-111436800	Active TSS	Right Atrium	heart
19	chr2:111435200-111437000	Active TSS	Rectal Smooth Muscle	rectum
20	chr2:111435200-111437200	Active TSS	Aorta	Aorta
21	chr2:111435400-111436800	Active TSS	Breast Myoepithelial Primary Cells	Breast
22	chr2:111435400-111436800	Active TSS	Primary T killer naive cells fromperipheralblood	blood
23	chr2:111435400-111436800	Active TSS	Brain Cingulate Gyrus	brain
24	chr2:111435400-111436800	Active TSS	Brain Germinal Matrix	brain
25	chr2:111435400-111436800	Active TSS	Fetal Intestine Small	intestine
26	chr2:111435400-111436800	Active TSS	Right Ventricle	heart
27	chr2:111435400-111437200	Active TSS	Ovary	ovary
28	chr2:111435400-111437400	Active TSS	Duodenum Smooth Muscle	Duodenum
29	chr2:111435800-111437000	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
30	chr2:111436000-111437000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr2:111436000-111437200	Flanking Active TSS	Primary hematopoietic stem cells	blood
32	chr2:111436200-111436800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
33	chr2:111436200-111436800	Flanking Active TSS	Primary B cells from cord blood	blood
34	chr2:111436200-111436800	Active TSS	Primary T helper 17 cells PMA-I stimulated	--
35	chr2:111436200-111436800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
36	chr2:111436200-111436800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr2:111436200-111436800	Flanking Active TSS	HMEC	breast
38	chr2:111436200-111436800	Flanking Active TSS	HUVEC	blood vessel
39	chr2:111436200-111436800	Flanking Active TSS	NH-A	brain
40	chr2:111436200-111436800	Flanking Active TSS	NHEK	skin
41	chr2:111436200-111436800	Flanking Active TSS	Osteobl	bone
42	chr2:111436200-111437000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
43	chr2:111436200-111437000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr2:111436200-111437000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
45	chr2:111436200-111437000	Flanking Active TSS	Adipose Nuclei	Adipose
46	chr2:111436200-111437400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
47	chr2:111436400-111436800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
48	chr2:111436400-111436800	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
49	chr2:111436400-111436800	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
50	chr2:111436400-111436800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links